Bladder Cancer Clinical Updates and Highlights from ASCO GU 2024
Dana-Farber Cancer Institute via YouTube
The Private Equity Associate Certification
Google AI Professional Certificate - Learn AI Skills That Get You Hired
Overview
Google, IBM & Meta Certificates — All 10,000+ Courses at 40% Off
One annual plan covers every course and certificate on Coursera. 40% off for a limited time.
Get Full Access
Watch a comprehensive clinical update presentation from Dana-Farber Cancer Institute's Lank Center for Genitourinary Oncology covering the latest bladder cancer research findings and trial results from ASCO GU 2024. Learn about key developments including the Ambassador Trial, EV32 Trial, and UPF Front Trial, gaining valuable insights into the latest advancements in bladder cancer treatment and clinical outcomes. Explore detailed analysis and expert commentary on these significant trials that are shaping the future of genitourinary oncology in this 23-minute educational session.
Syllabus
Intro
Ambassador Trial
EV32 Trial
UPF Front Trial
Comments
Taught by
Dana-Farber Cancer Institute